Actively Engaging Target bio/pharma partnerships centered on long acting injectable delivery: Innocore’s proprietary SynBiosys biodegradable polymer platform and expertise in peptides, biologics, and small molecules position them for collaborations with developers seeking extended release formulations and minimally invasive administration.

Global Conference Outreach capitalize on their active participation in major industry events (NLSDays, BIO International, DDF Summit, Bio-Europe Spring) by arranging pre-event meetings, joint webinars, or co-presentations to accelerate relationship building with potential CDMOs, pharma sponsors, and device manufacturers.

Funding Readiness With revenue under a million and a focused niche in long acting injectables, Innocore could be an attractive partner for early-stage collaborations, licensing deals, and milestone-driven programs that minimize upfront investment while enabling access to their tunable polymer technology.

Clinical & Regulatory Alignment Leverage their capabilities in maintaining stability and enabling small needle injectables to address regulatory and patient compliance needs, presenting opportunities to companies facing stability/toxicity challenges in biologics and peptide therapeutics.

Target Market Fit Position Innocore as a specialized premium partner for biotech and pharma companies developing long-acting formulations, offering a differentiated value proposition in particle size control, sustained release, and compatibility with low-temperature manufacturing.